Issues related to Part D rebates Proposals related to drug pricing, drug price transparency, PBMs Implementation of the Inflation Reduction Act
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 18, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ALPINE GROUP PARTNERS, LLC.
- Client
- AMGEN
- Filing UUID
- 94b0ffe3-a669-4ce6-a122-e76139627708
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.